Effective from 1 September 2016 there will be a new Atorvastatin listed in the Pharmaceutical Schedule and HML.
Lorstat will come in 500 packs of all four strengths at a significantly reduced Price & Subsidy.
From 1 September 2016 to 31 October 2016 both Zarator and Lorstat will be Fully Funded.
From 1 November 2016 only Lorstat will be Fully Funded, however Zarator will remain listed and partially funded.
Click here to read the information available from Pfizer in relation to the future changes for Zarator.
Effective 1 February 2017 only Lorstat will listed.
Click here to see details relating to Lorstat.
Pharmacy must take into account all factors and provide the best outcome for the patient. Keep in mind also the cost associated to your business in this process.